SELLAS Life Sciences SLS
NASDAQ SLS
$13.85 +0.15 (+1.13%)
As of: Sep 4, 2026 · 3:59 PM EDT

SELLAS Life Sciences (SLS) Amortization - Intangibles (2013 - 2015)

SELLAS Life Sciences (SLS) posted quarterly Amortization - Intangibles of $442000.0 for Q2 2015, up 351.02% year-over-year from $98000.0 in Q2 2014, and up 202.74% quarter-over-quarter from $146000.0 in Q1 2015.

Analysis

SELLAS Life Sciences (SLS) Amortization - Intangibles (2013 - 2015) Analysis & Trends

SELLAS Life Sciences (SLS) has reported Amortization - Intangibles for 3 consecutive years, with $442000.0 the latest figure, recorded in Q2 2015.

  • In Q2 2015, Amortization - Intangibles rose 351.02% year-over-year to $442000.0; the TTM figure through Jun 2015 stood at $756000.0 (up 225.86% YoY), while the FY2017 annual figure was $1.9 million, changed N/A from the prior year.
  • Amortization - Intangibles rose to $442000.0 in Q2 2015 per SLS's latest filing, from $146000.0 in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $442000.0 in Q2 2015 and bottomed at $43000.0 in Q3 2013.
  • Historically, Amortization - Intangibles has averaged $148333.3 across 3 years, with a median of $94500.0 in 2014.
  • On a YoY basis, Amortization - Intangibles climbed as much as 351.02% in 2015 and fell as far as 60.44% in 2015.
  • SELLAS Life Sciences' Amortization - Intangibles stood at $43000.0 in 2013, then jumped by 62.79% to $70000.0 in 2014, then soared by 531.43% to $442000.0 in 2015.
  • Business Quant data shows SLS's Amortization - Intangibles at $442000.0 in Q2 2015, $146000.0 in Q1 2015, and $70000.0 in Q3 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 SELLAS Life Sciences 2.62 Bn 2.62 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 442,000.00
Mar 31, 2015 146,000.00
Sep 30, 2014 70,000.00
Jun 30, 2014 98,000.00
Mar 31, 2014 91,000.00
Sep 30, 2013 43,000.00